An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
基本信息
- 批准号:9752622
- 负责人:
- 金额:$ 56.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposed project is for developing the second-generation MR-compatible SPECT system (MRC-SPECT-
II). The proposed MRC-SPECT-II system, based on a novel inverted compound-eye (ICE) gamma camera
design would offer the potential of dramatically improving SPECT imaging instrumentation from several
aspects. First, this approach helps to tackle one of the most limiting aspects of SPECT instrumentation, by
offering a dramatically improved sensitivity without sacrificing its resolution capability. The proposed MRC-
SPECT-II system could offer an unprecedented sensitivity of 1.5% with a reconstructed imaging resolution of
0.5 mm across and 1.5 cm diameter field-of-view (FOV), and 9% at 1.2 mm spatial resolution (as compared to
the typical levels of 0.1% - 0.01% found in modern pre-clinical SPECT instrumentations). This greatly increase
in detection sensitivity could potentially provide a radical change in how we might employ SPECT imagining in
pre-clinical research by offering a dramatically lowered detection limit and allowing for new imaging procedures
that would not be feasible with the current generation of SPECT instrumentations. Second, the ICE-camera
design allows the MRC-SPECT-II system to have a significantly reduced physical dimension, while compared
to any existing SPECT systems with similar FOV. This would allow the MRC-SPECT-II system (and future
MRC-SPECT systems based on similar ICE camera design) to be integrated in most of existing MR scanners.
Third, the ICE camera design could also offer dramatically improved sensitivities for scaled-up SPECT
scanners for large animals and for human (e.g. brain and heart) imaging applications. Finally, the proposed
MRC-SPECT-II system allows for simultaneous SPECT and high-field (9.4T) MR imaging studies. Within this
particular project, the MRC-SPECT-II system will be developed and refined for in vivo study of the efficacy and
fate of therapeutically engineered neural stem cells in malignant brain tumors, which could help to bring this
promising therapeutic approach into clinical practice.
该提出的项目用于开发第二代MR兼容SPECT系统(MRC-Spect--
ii)。拟议的MRC-spect-II系统,基于一种新颖的倒置化合物(ICE)伽马相机
设计将提供从几种巨大改进Spect Imaging仪器的潜力
方面。首先,这种方法有助于解决Spect Instrumentation的最限制方面之一
提供明显提高的灵敏度,而无需牺牲其分辨率。提议的MRC-
Spect-II系统可以通过重建成像分辨率的前所未有的灵敏度为1.5%
跨直径为0.5毫米,视野(FOV)为1.5 cm,在1.2 mm空间分辨率下(与
在现代临床前光谱仪器中发现的0.1%-0.01%的典型水平)。这大大增加了
在检测中,灵敏度可能会在我们可能想象中采用Spect的方式有根本性的改变
临床前研究通过提供大幅降低的检测极限并允许新成像程序
对于当前的Spect仪器,这是不可行的。第二,冰摄像机
设计允许MRC-Spect-II系统具有显着降低的物理维度,同时比较
对于具有类似FOV的任何现有SPECT系统。这将允许MRC-Spect-II系统(以及未来
基于类似冰心摄像机设计的MRC-spect系统将集成在大多数现有MR扫描仪中。
第三,冰相机设计还可以极大地提高敏感性,以缩放SPECT
大型动物以及人类(例如大脑和心脏)成像应用的扫描仪。最后,提议
MRC-Spect-II系统允许同时进行SPECT和高场(9.4T)MR成像研究。在此
特定项目,将开发和完善MRC-spect-II系统,以在体内研究功效和
在恶性脑肿瘤中治疗设计的神经干细胞的命运,这可能有助于带来
有希望的临床实践治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Chin-Tu Chen的其他基金
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
- 批准号:98973659897365
- 财政年份:2020
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
- 批准号:1054477910544779
- 财政年份:2020
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01
- 批准号:1031406310314063
- 财政年份:2020
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
Improved Radiation Therapy of Hypoxic Tumor Regions by Integrated PET, EPR, and MR Imaging - Resubmission 01 - Revision - 1
通过集成 PET、EPR 和 MR 成像改进缺氧肿瘤区域的放射治疗 - 重新提交 01 - 修订版 - 1
- 批准号:1028958210289582
- 财政年份:2020
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:99195369919536
- 财政年份:2017
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:94036639403663
- 财政年份:2017
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
a4b2 烟碱受体上调和戒烟的 PET 成像
- 批准号:1015256210152562
- 财政年份:2017
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:92520729252072
- 财政年份:2016
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:93534049353404
- 财政年份:2016
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
An Ultra High Resolution SPECT System Integrated with a High-Field MRI Scanner
与高场 MRI 扫描仪集成的超高分辨率 SPECT 系统
- 批准号:84960388496038
- 财政年份:2011
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Measuring Intralesional Bedaquiline Exposures in Cavitary TB Using Noninvasive In Vivo PET Imaging
使用无创体内 PET 成像测量空洞结核病灶内贝达喹啉暴露
- 批准号:98943009894300
- 财政年份:2020
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
Positive allosteric modulation of cholinergic receptors in recovery after brain trauma
脑外伤后恢复过程中胆碱能受体的正变构调节
- 批准号:90933369093336
- 财政年份:2016
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:92520729252072
- 财政年份:2016
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
An MR-Compatible Small Animal SPECT Based on Artifical Compound Eye Cameras
基于人工复眼相机的 MR 兼容小动物 SPECT
- 批准号:93534049353404
- 财政年份:2016
- 资助金额:$ 56.65万$ 56.65万
- 项目类别:
Dopamine, mutant synuclein, oxidative stress and inflammation
多巴胺、突变突触核蛋白、氧化应激和炎症
- 批准号:79295477929547
- 财政年份:2009
- 资助金额:$ 56.65万$ 56.65万
- 项目类别: